Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers. Murakami H, Hayashi M, Terada S, Ohmichi M, et al. Life Sci 2023;325:121753.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Murakami H, Hayashi M, Terada S, Ohmichi M, et al. Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers. Life Sci 2023;325:121753.
PMID: 37160245